Saira Mirza

Pharmacist



  
  3101 Beaumont Centre Cir Ste 100, Lexington
Kentucky, 40513-1959

 859-562-2751   
Saira Mirza is a pharmacist in Lexington, Kentucky. Patients can reach her at 3101 Beaumont Centre Cir Ste 100, Lexington or contact her on 859-562-2751. Active license number of Saira Mirza is 025236 for Pharmacist in Kentucky.
Saira Mirza is


Complete Profile:
Saira Mirza speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Saira Mirza
Specialization: Pharmacist
Credentials:PHARMD
Gender:Female
Location:3101 Beaumont Centre Cir Ste 100, Lexington,
Kentucky, 40513-1959
Phone:859-562-2751
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Saira Mirza are as mentioned below.
NPI Number: 1750253423
NPI Enumeration Date: 22 Sep, 2025
NPI Last Update On: 22 Sep, 2025

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Saira Mirza are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist 025236KentuckyPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 3101 Beaumont Centre Cir Ste 100,
Lexington, Kentucky
Zip: 40513-1959
Phone Number: --
Patients can reach Saira Mirza at 3101 Beaumont Centre Cir Ste 100, Lexington, Kentucky or can call on phone at 859-562-2751.

Comments/ Reviews:
Read all the reviews posted for Saira Mirza below. You may also share your own experience with Saira Mirza. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.